Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 471-477

  Gao, Chengcheng ^a   Pang, Liqun ^a   Ren, Chengcheng ^a   Ma, Tianheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Prognosis; Raf kinase inhibitor protein

Indexed keywords

B RAF KINASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84863464129     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9470-z     Document Type: Article

References (24)

1. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin 49:8-31
2. Yu WW, Guo YM, Zhu M, Cai XW, Zhu ZF, Zhao WX, Fu XL (2011) Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: a meta-analysis. Hepatogastroenterology 58:426-431
3. Liu J, Hu Y, Hu W, Xie X, Ela Bella A, Fu J, Rao D. (2011) Expression and prognostic relevance of p21(WAF1) in stage III esophageal squamous cell carcinoma. Dis Esophagus. In press.
4. Keller ET, Fu Z, Brennan M (2004) The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 68:1049-1053
5. Keller ET (2004) Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP). Anticancer Drugs 15:663-669
6. Trakul N, Rosner MR (2005) Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res 15:19-23
7. Bernier I, Jolles P (1984) Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochim Biophys Acta 790:174-181
8. Khamis ZI, Iczkowski KA, Sang QX. (2011) Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents. Med Res Rev. In press.
9. Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z (2009) Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 7:832-840
10. Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, Cai MY, Ju MJ, Zhou J, Zhang BH, Fan J (2010) PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol 53:872-879
11. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B (2007) Regulation of tumor cell sensitivity to TRAILinduced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 179:5441-5453
12. Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721-1724
13. Wang J, Yang YH, Wang AQ, Yao B, Xie G, Feng G, Zhang Y, Cheng ZS, Hui L, Dai TZ, Du XB, Wang D (2010) Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27:219-223
14. Zaravinos A, Chatziioannou M, Lambrou GI, Boulalas I, Delakas D, Spandidos DA (2011) Implication of RAF and RKIP Genes in Urinary Bladder Cancer. Pathol Oncol Res 17:181-190
15. Baritaki S, Bonavida B (2010) Viral infection and cancer: the NFkappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. Crit Rev Immunol 30:31-46
16. Wu K, Bonavida B (2009) The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29:241-254
17. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878-889
18. Biewenga P, Buist MR, Moerland PD, Loren V, van Themaat E, van Kampen AH, ten Kate FJ, Baas F (2008) Gene expression in early stage cervical cancer. Gynecol Oncol 108:520-526
19. Ruan L, Wang GL, Yi H, Chen Y, Tang CE, Zhang PF, Li MY, Li C, Peng F, Li JL, Chen ZC, Xiao ZQ (2010) Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110:975-981
20. Al-Mulla F, Hagan S, Al-Ali W et al (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61:524-529
21. Minoo P, Zlobec I, Baker K et al (2007) Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 127:820-827
22. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M (2006) Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 131:1208-1217
23. Hagan S, Al-Mulla F, Mallon E et al (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392-7397
24. Park S, Yeung ML, Beach S, Shields JM, Yeung KC (2005) RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 24:3535-3540